Pulse pressure, a measure of central arterial stiffness and a predictor of cardiovascular mortality, has known genetic components.
articles QTLs for Pulse Pressure protocol across the three recruiting centers. 14 Forearm seated blood pressures were measured three times by a trained technician using a mercury column sphygmomanometer (WA Baum, Copiague, NY) and size-adjusted cuffs. The first and fifth Korotkoff sounds were recorded. The average of the last two of the three measures was used in the analyses. Pulse pressure was calculated using the difference between the SBP and DBP. We also estimated the mean arterial pressure using the equation DBP+ (pulse pressure/3). Anthropometric measures of height and weight were used to calculate body mass index (BMI).
Hypertension was defined using the 7th Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure as blood pressure levels of 140/90 mm Hg or higher, or use of antihypertensive drugs. The American Diabetes Association criteria of fasting plasma glucose levels ≥126 mg/dl, treatment with oral agents or insulin were used to define diabetes mellitus. Categories of obesity were defined using the National Institutes of Health guidelines as normal (BMI < 25 kg/m 2 ), overweight (BMI of 25 to <30 kg/m 2 ), and obese (BMI ≥ 30 kg/m 2 ) (Supplementary References online). Albumin and creatinine were measured in a random urine sample using nephelometric immunochemistry and alkaline picrate methods, respectively. 15 Urine albumin to creatinine ratio (ACR, mg/g) was used in analyses. Serum creatinine was measured by the picric acid method. 15 The aortic root diameter was measured at the sinuses of Valsalva with the parasternal long-axis view using phased-array echocardiographs with M-mode, two-dimensional, pulsed, continuous, and color-flow Doppler capabilities as described previously. 16 Genotyping. Genotype data were generated using the ABI PRISM Linkage Map Set-MD10 which includes ~400 markers spaced at ~10 cM intervals (Supplementary References, online). Pedigree relationships have been verified using the PREST (Pedigree RElationship Statistical Tests) package, which employs likelihood-based inference statistics for genome-wide identity-by-descent allele sharing. Mendelian inconsistencies and spurious double recombinants were detected using the SimWalk2. Marker allele frequencies were derived using maximum likelihood methods estimated from all individuals. The overall blanking rate for both types of errors was <1% of the total number of genotypes for Arizona, the Dakotas, and Oklahoma. Multipoint identity-by-descent matrices were computed using LOKI 2.4. Our chromosomal maps are based on the deCODE map. We used the University of California Santa Cruz website (http://genome.ucsc.edu) and Online Mendelian Inheritance in Man (http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?db=OMIM) databases to determine the cytogenic location of markers and to search for candidate genes.
Statistical analyses. We used generalized linear models to estimate the mean age-adjusted blood pressure in categories of potential confounders ( Table 1) . Quantitative traits with skewed distributions were log-transformed (pulse pressure, BMI, ACR, and SBP). We obtained residuals from linear regression predictive models of the log of pulse pressure using a backwards elimination strategy (α = 0.10) in SAS version 9.1 (Cary, NC). A minimally adjusted model accounted for the effects of age, age 2 , sex, and age-by-sex interaction within center (Model 1). Additional models adjusting for smoking (ever vs. never), alcohol intake (current vs. not), continuous log-transformed BMI, continuous log-transformed ACR, and type 2 diabetes and hypertension treatment (yes vs. no) were also performed (Model 2). In addition, we explored models adjusting for aortic root diameter. The residuals' kurtoses from minimal and maximal models were 0.42 and 0.75, respectively.
Heritability was estimated using maximum likelihood variance decomposition methods. 17 Multipoint variance component genome-wide linkage analyses were then performed using SOLAR version 2.1.4. 17 The variance component approach tests for linkage between marker loci and the trait by partitioning articles QTLs for Pulse Pressure the phenotypic variance into its additive genetic and environmental variance components and has been described in detail elsewhere. 17 We determined the 1-LOD unit drop support interval for all suggestive linkage results with a LOD score ≥1.8. 18 Family-specific LOD scores were computed using pedlod in SOLAR. Linkage heterogeneity (joint test of linkage and heterogeneity) was estimated using hlod in SOLAR and an α = 0.0001. We performed power calculations for a quantitative trait assuming that the trait was influenced by a single bi-allelic QTL and a residual additive genetic effect due to polygenes, using power in SOLAR (see Supplementary Table S1 online). In addition, we performed analysis of SBP, DBP, and mean arterial pressures to determine whether identified QTLs for pulse pressure were also influencing other blood pressure phenotypes.
Genotype-by-environment interaction analyses.
To test for additive genotype-by-environment interaction, the univariate variance component model was extended to include the genetic covariance between the two environment relative pairs. 19 The likelihood of a model including genotype-byenvironment interaction is compared with the likelihood of restricted models in which such interactions are excluded. We tested a model in which the genetic correlation (ρG) between the two groups is constrained to 1.0; and a model in which the genetic variance (σ g ) among groups is constrained to be equal. In addition, we tested a model in which the environment (residual) variances (σ e ) among the two groups were constrained to be equal. For genotype-by-sex interaction models, log-transformed pulse pressure trait was adjusted for age, and recruiting centers. For genotype-by-age interaction, we used residuals of a linear model adjusting for sex and recruiting center, and a 50 year age cutpoint categorical variable. We also performed linkage analyses including the QTL-specific interaction term when significant (described in Supplementary Methods online).
results
Analyses were performed using an available subset of 1,892 of the total 3,600 individuals that have been genotyped in 14 large pedigrees. Among 18,349 relative pairs, 1,530 were parent-offspring pairs, 1,381 were sibling pairs, and 2,703 were avuncular pairs. Sixty-two percent of subjects were women, and the mean age for all participants was 42 years (s.d., 16). Subjects were often smokers (58%) and overweight or obese (mean BMI of 32 kg/m 2 ) ( Table 1) . Hypertension (34%) and diabetes (23%) were highly prevalent. Mean aortic root diameter was 3.3 cm (s.d., 0.4) and mean serum creatinine 0.8 (s.d., 0.4) mg/dl. Microalbuminuria or macroalbuminuria was present in ~19% of individuals (Table 1) . Overall, the unadjusted mean pulse pressure was 46 mm Hg (s.d., 14) . Pulse pressure increased after age 50, and the ageadjusted mean pulse pressure was similar among men and women ( Table 1) . Mean pulse pressure was also increased in hypertensive and diabetic subjects but not among smokers, those with current alcohol intake, or obese participants. In addition, pulse pressure was elevated in increasing levels of urine albumin excretion ( Table 1) . For comparison, the mean age-adjusted SBP and DBP are also displayed in Table 1 . In linear regression models, age, sex, smoking exposure, hypertension treatment, continuous log BMI, and log ACR (P < 0.01 for all) were significant predictors of pulse pressure variation, which was not so for alcohol intake (P = 0.10), type 2 diabetes (P = 0.22), or aortic root diameter (P = 0.31).
The estimated residual heritability of log of pulse pressure adjusted for age, age 2 , sex, age-by-sex interaction, and center was 0.25 (s.e. = 0.04, P = 1.3 × 10 −12 ). We identified a QTL influencing pulse pressure on chromosome 7 at 37 cM (marker D7S493, LOD score 3.3, Figure 1 ) and suggestive evidence of linkage on chromosome 19 at 92 cM (marker D19S888, LOD = 1.8, Figure 2 ) in models adjusted for age, sex, and center. The 1-LOD support interval of the signal on chromosome 7 spanned from 32 cM (near marker D7S507) to 44 cM (marker D7S516) (Figure 1) . Adjusting for continuous log BMI, alcohol exposure, diabetes, and hypertension treatment did not substantially change the magnitude of the signal on chromosome 7 or 19, but additional adjustments for smoking exposure or log ACR attenuated the signal in chromosome 7 (LOD = 2.4 and 2.6, respectively) (Figure 1) but not the signal on chromosome 19 (Figure 2) . Minimally and maximally adjusted models for all chromosomes are shown in Supplementary Figure S1 online. Finally, models adjusting for aortic root diameter did not change our peak linkage signals on both chromosomes 7 and 19 (data not shown).
Although multiple families contributed to the described LOD score on chromosome 7, the highest family-specific LOD scores were found in two large pedigrees in Dakota and Oklahoma (LOD scores of 1.4 and 2. Figure 1 | Chromosome 7 multipoint LOD scores for log-transformed pulse pressure. Model 1: log pulse pressure adjusted for age, age 2 , sex, age-by-sex interaction, center; Model 2: log pulse pressure adjusted for age, age 2 , sex, age-by-sex interaction, center, diabetes, smoking, log urine albumin excretion, log body mass index (bMI), hypertension treatment; Model 3: Model 2 without adjusting for log urine albumin excretion (smoking effect); Model 4: Model 2 without adjusting for smoking (urine albumin excretion effect). Figures S3 and S4 online) .
In separate analysis using sex-specific residuals, we found no sex-specific additive genetic effects for pulse pressure (ρG = 0.50, P = 0.09 for interaction by sex). However, we found a significant genotype-by-age interaction for pulse pressure in models adjusting for sex and center, and using the age category cutpoint of 50 years (ρG = −0.27 ± 0.12, P = 1.41 × 10 −9 ). The signal on chromosome 7 was attenuated in linkage analysis including the age interaction term (LOD score = 1.8) and the chromosome 19 QTL was not detected.
discussion
We identified two QTLs influencing pulse pressure in American Indians: one of the QTLs shows significant evidence of linkage on chromosome 7 and the other shows suggestive evidence for linkage on chromosome 19. Our findings were consistent across different models of covariates adjustment, including adjustments for the effects of age, sex, BMI, diabetes, alcohol intake, aortic root diameter, and hypertension treatment. However, the magnitude of the linkage peak for pulse pressure on chromosome 7 was slightly attenuated when adjusting for smoking status or albuminuria, both of which are genetically determined.
Studies in US Caucasian and African-American individuals identified QTLs for pulse pressure and other blood pressure related traits on chromosomes 7 and 19, but our study is the first to detect genome-wide significant linkage to this region. 10, 11 The pulse pressure QTL identified at 7p15.3 overlaps positive findings for pulse pressure among Caucasian Utah population participants selected for early coronary artery disease, stroke, or early onset hypertension (LOD = 1.8, marker D7S1808), at ~6 Mb away from our linkage peak. 11 This QTL is also within 40 Mb of a QTL for pulse pressure identified among 779 Family Blood Pressure Program GenNet African American participants (LOD = 3.1, marker D7S3046) 10 and among 1,584 participants of the Framingham Heart Study (LOD = 2.4, located at 71 cM of chromosome 7). 12 Also of interest, a QTL for carotid artery intimal-medial thickness, a measure of subclinical atherosclerosis associated with increased pulse pressure, was recently identified in a nearby region on chromosome 7 (at 7p14.3) among the Offspring cohort of the Framingham Heart Study (LOD = 1.6). 21 In addition, a QTL for carotid-femoral pulse wave velocity, a more direct measure of aortic stiffness, was identified on chromosome 7 at 29 cM in the Framingham Heart Offspring Study. 22 The QTL on chromosome 19q has also been previously described by Camp et al. for pulse pressure (marker D19S245, LOD = 2.0) and more recently by the National Heart, Lung, and Blood Institute Family Blood Pressure Program in African-American subjects (LOD = 2.3). 10, 11 Although a recent meta-analysis of pulse pressure linkage studies did not identify chromosome 7 or 19 as regions of interest for pulse pressure, the study reported evidence for substantial genetic heterogeneity for this trait. 13 Approximately 86 genes underlie the 1-LOD support interval of the 7p15.3 QTL, of which two positional candidate genes have been associated with hypertension and/or atherosclerosis: interleukin-6 (IL-6 at 7p21) and neuropeptide Y (NPY at 7p15.1). IL-6 is an acute inflammatory cytokine and an inducer of C-reactive protein. High levels of IL-6 were seen in hypertension and increased pulse pressure, 23 and were also associated with the development and the progression of atherosclerosis and cardiovascular disease mortality. 24 A polymorphism in the promoter of the IL-6 gene (−174G/C) was associated with increased carotid artery intimal-medial thickness 25 and coronary artery disease 26 but has not been studied in association with pulse pressure. Neuropeptide Y is a vasoactive neuropeptide that regulates appetite and vascular reactivity. Polymorphisms of NPY were associated with hypertension, increased carotid artery intimal-medial thickness, 27 myocardial infarct, and stroke. 28 In addition, NPY variants were associated with insulin resistance 29 which is highly prevalent in American Indians in the Strong Heart Study.
Located in the chromosome region 19q13.3-13.41 is a cluster of 15 genes of the kallikrein family. Kallikreins are tissue-specific enzymes that generate kinins, which affect blood pressure and renal function. Variants of the kallikrein 1 (KLK1) gene are associated with hypertension in Han Chinese populations. 30 The identified QTL on chromosome 7 was specific to the pulse pressure phenotype, but the QTL on chromosome 19 was also localized using the SBP trait. The Family Blood Pressure Figure 2 | Chromosome 19 multipoint LOD scores for log-transformed pulse pressure. Model 1: log pulse pressure adjusted for age, age 2 , sex, age-by-sex interaction, center; Model 2: log pulse pressure adjusted for age, age 2 , sex, age-by-sex interaction, center, type 2 diabetes, smoking, log urine albumin excretion, log body mass index (bMI), hypertension treatment; Model 3: Model 2 without adjusting for log urine albumin excretion (smoking effect); Model 4: Model 2 without adjusting for smoking (urine albumin excretion effect). Program has also showed some overlap between SBP and pulse pressure QTLs. 10 Interestingly, we did not see an overlap in QTLs for pulse pressure and mean arterial pressure, the latter measure being the steady-flow component of the blood pressure curve. Minimal overlap in linkage peaks to blood pressure components have also been previously reported. 12, 31 We identified an interesting genotype-by-age interaction for pulse pressure, supporting a genetic basis for the physiologic differences observed in pulse pressure in young compared to older individuals. In linkage analysis accounting for age interaction, the QTL on chromosome 7 was attenuated and the evidence for linkage on chromosome 19 disappeared. These findings may be due to differences in the age effects within categories of risk factors for atherosclerosis, for example, the age effects may vary with gender or hypertensive status. In addition, reduced power to detect the effects may occur when using age categories. Lastly, the possibility that the chromosome 19 QTL is a false positive must also be considered. Further studies are needed to clarify the relationship between genotype, age, and pulse pressure.
Our study used averages of two blood pressure measures for estimation of pulse pressure, which decrease the variability of the blood pressure trait. Misclassification of hypertension status could have occurred for individuals classified based on the single day average measure of blood pressure (36% of hypertensive individuals were classified using only blood pressure measures). Although two large families accounted for most of the linkage signal on chromosome 7, the joint test of heterogeneity and linkage was not significant, indicating that all families contributed to the linkage signal.
In summary, we found genome-wide evidence for linkage to pulse pressure on chromosome 7p and suggestive evidence for linkage on 19q among American-Indian participants of the SHFS. Our study provides corroboration of genomic regions that possibly influence interindividual variation in pulse pressure on chromosomes 7p and 19q. In addition, the 7p region encompasses candidate genes known to affect blood pressure and hypertension, as well as markers of subclinical atherosclerosis. The identification and confirmation of QTLs for pulse pressure will bring us closer to the identification of the functional genes that influence pulse pressure and aid in disentangling the complex etiology of cardiovascular disease.
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